Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
9(56%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
9
56%
Ph phase_2
1
6%
Ph phase_1
6
38%

Phase Distribution

6

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
6(37.5%)
Phase 2Efficacy & side effects
1(6.3%)
Phase 3Large-scale testing
9(56.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

9

trials recruiting

Total Trials

16

all time

Status Distribution
Active(12)
Completed(4)

Detailed Status

Recruiting9
Completed4
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
16
Active
9
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (37.5%)
Phase 21 (6.3%)
Phase 39 (56.3%)

Trials by Status

completed425%
not_yet_recruiting319%
recruiting956%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT07571005Phase 3

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Recruiting
NCT07571109Phase 3

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Recruiting
NCT07533175Phase 3

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Recruiting
NCT07503210Phase 3

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

Recruiting
NCT07509307Phase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Recruiting
NCT07587710Phase 1

A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver Function

Not Yet Recruiting
NCT07481630Phase 3

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Recruiting
NCT07339423Phase 3

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Recruiting
NCT07567001Phase 3

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Not Yet Recruiting
NCT07508020Phase 1

A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity

Recruiting
NCT07535307Phase 1

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

Recruiting
NCT07400107Phase 3

AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Not Yet Recruiting
NCT06064006Phase 2

A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin

Completed
NCT06820476Phase 1

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing

Completed
NCT06559527Phase 1

A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function

Completed
NCT06049329Phase 1

A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16